It has now been 6 months since the PROUD and IPERGAY clinical studies investigating Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV infection had to change course due to the success of the antiretrovirals (ARV) used in these trials to prevent HIV acquisition in HIV
TL;DR: PROUD and IPERGAY studies show PrEP reduces risk of HIV infection by 86% – How many more infections needed before Truvada is available on the NHS for the prevention of HIV in the UK? It is now official, Pre-Exposure Prophylaxis (PrEP) works for the
Latest UNAIDS report shows that 35 million people are living with HIV in 2013. Since the start of the epidemic, around 78 million people have been infected with the virus that causes AIDS and 39 million people have died of AIDS-related illnesses. In the UK alone,
A group of UK HIV prevention organisations have released today a statement calling for the NHS to make Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV infection available as soon as possible. This statement comes after two clinical studies investigating daily PrEP in the UK
In a recent BMJ Blog Dr Rupert Whitaker cast a critical eye on Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV infection, questioning its role as a public health intervention. The piece is challenging and although it rightly emphasises the need for a carefully planned